Patients Radiation Exposure in Percutaneous Transhepatic Biliary Drainage

Status Completed

Clinical Trial Summary

Percutaneous transhepatic biliary drainage (PTBD) procedures are associated with an elevated radiation exposure for the patient. In the recently published guideline of the Federal Ofﬁce for Radiation Protection in Germany diagnostic reference levels (DRLs) for dose area products (DAP) are not defined for PTBD procedures due to insufficient data. The aim of this retrospective study is to give a nation-wide survey on patients radiation exposure in different PTBD procedures considering factors that may have an impact on increased radiation exposure like fluoroscopic-guided versus ultrasound-guided bile duct puncture.

Clinical Trial Description

Percutaneous transhepatic biliary drainage (PTBD) procedures are associated with an elevated radiation exposure for the patient. Usually, radiation exposure in radiological interventions is measured by the dose area product (DAP). Diagnostic reference levels (DRLs) are based on the third quartiles (Q3) of the pooled dose area product (DAP) for the known interventional procedures. They have been introduced in the 1980s by the International Commission on Radiological Protection's (ICRP's) to reduce patients radiation exposure. In the recently published guideline of the Federal Ofﬁce for Radiation Protection in Germany in 2016 DRLs are not defined for PTBD procedures due to insufficient data. Procedure complexity due to different techniques, patient anatomy, lesion characteristics and disease severity makes it difficult to define DRLs in this fluoroscopy-guided intervention. The ICRP recently published some recommendations on DRLs in medical imaging including radiological interventions. As DRLs are often missing in this field, it was suggested to analyze national data sets comprising dosimetric data from a large number of facilities. The aim of this retrospective study is to give a nation-wide survey on patients radiation exposure in different PTBD procedures considering factors that may have an impact on increased or decreased radiation exposure like fluoroscopic-guided versus ultrasound-guided bile duct puncture. A questionnaire was sent to 200 gastroenterological and radiological departments in university and non-university hospitals to analyze the last 10 - 30 consecutively performed PTBD procedures. ;

Study Design

Related Conditions & MeSH terms

Radiation Exposure

Clinical Trial Details

NCT number	NCT03538782
Study type	Observational
Source	Theresienkrankenhaus und St. Hedwig-Klinik GmbH
Contact
Status	Completed
Phase
Start date	March 15, 2018
Completion date	October 15, 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03649451` - Reference Dose Levels During Fluoroscopically Guided Procedures in Operating Rooms
Completed	`NCT03305978` - Pulmonary Nodule Detection: Comparison of an Ultra Low Dose vs Standard Scan.	N/A
Recruiting	`NCT04139096` - Genetic Susceptibility to Radiation Induced Thyroid Cancer
Completed	`NCT01424774` - Prospective Evaluation of Strontium in Patients After CardioGen-82 PET MPI Scanning	N/A
Completed	`NCT01430975` - Prospective Evaluation of Strontium in Patients After CardioGen-82 PET MPI Scanning at Two Clinical Sites	N/A
Completed	`NCT00378053` - A Prospective Study of Radiation Exposure to Surgeons	N/A
Recruiting	`NCT05561439` - Individual Dosimetric Monitoring of Workers During Interventional Radiology and Cardiology Procedures for Cardiologists and Radiologists in France
Completed	`NCT04078165` - Suspended Personal Protection System Versus Conventional Protection (Aka Zero-Gravity vs Shield and Apron)	N/A
Recruiting	`NCT04694391` - Genomic Study of Relapse Esophageal Cancer After Radiotherapy
Not yet recruiting	`NCT04403815` - Radiation Exposure During Coronary Procedures According to Vascular Access
Recruiting	`NCT04285944` - Operator Radiation Protection During Cardiac Catheterization Using Mavig X-ray Protective Drapes®.	N/A
Completed	`NCT04363190` - Genomic Instability in Vascular Surgeons
Completed	`NCT04404257` - Reduce Radiation Exposure in Fluoroscopic Interventions Evaluation	N/A
Recruiting	`NCT04678258` - Zero Fluoroscopy Voltage Guided vs. Linear CTI Ablation	N/A
Recruiting	`NCT03386500` - Safety Study of BMX-001 (Radio-protector) in Patients With Newly Diagnosed Anal Cancer	Phase 1/Phase 2
Recruiting	`NCT05833516` - Hyper Adduction of Right Radial Artery/Arm vs Left Drag Over Technique
Recruiting	`NCT03946280` - Utility of 3D Navigation to Reduce Ionizing Radiation in Common Flutter Ablation. Study of Personnel and Patient Dosimetry	N/A
Completed	`NCT03985488` - Radiation Exposure Assessment in Fluoroscopy
Completed	`NCT03605030` - Reducing Radiation Exposure to Operators During Invasive Cardiac Procedures	N/A
Recruiting	`NCT02689908` - Individualized Radiation Dose Control	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Patients Radiation Exposure in Percutaneous Transhepatic Biliary Drainage (PTBD) Procedures

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms